Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts

References

• Nicholls SJ, Rye KA, Barter PJ. High-density lipoproteins as therapeutic targets. Curr Opin Lipidol 2005; 16: 345–349
   PubMed Web of Science ®Google Scholar
• Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004; 95: 764–772
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Dousset N, Ferretti G, Bacchetti T, Curatola G, Salvayre R. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med 2006; 41: 1031–1040
   PubMed Web of Science ®Google Scholar
• Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 1987–1994
   PubMed Web of Science ®Google Scholar
• Birjmohun RS, van Leuven SI, Levels JH, van't Veer C, Kuivenhoven JA, Meijers JC, Levi M, Kastelein JJ, van der Poll T, Stroes ES. High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 2007; 27: 1153–1158
   PubMed Web of Science ®Google Scholar
• Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129–135
   PubMed Web of Science ®Google Scholar
• Graham A, Hassall DG, Rafique S, Owen JS. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis 1997; 135: 193–204
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Shimada K, Sato O, Kotani K, Kume A, Sumiyoshi K, Sato Y, Ohmura H, Watanabe Y, Mokuno H, Daida H. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. Atherosclerosis 2005; 179: 139–145
   PubMed Web of Science ®Google Scholar
• Kontush A, de Faria EC, Chantepie S, Chapman MJ. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 2005; 182: 277–285
   PubMed Web of Science ®Google Scholar
• Mackness B, Quarck R, Verreth W, Mackness M, Holvoet P. Human paraoxonase-1 over-expression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol 2006; 26: 1545–1550
   PubMed Web of Science ®Google Scholar
• Kopprasch S, Pietzsch J, Graessler J. The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL. Mol Cell Biochem 2004; 258: 121–127
   PubMed Web of Science ®Google Scholar
• Cettour-Rose P, Nguyen TX, Serrander L, Kaufmann MT, Dayer JM, Burger D, Roux-Lombard P. T cell contact-mediated activation of respiratory burst in human polymorphonuclear leukocytes is inhibited by high-density lipoproteins and involves CD18. J Leukoc Biol 2005; 77: 52–58
   PubMed Web of Science ®Google Scholar
• Lee CM, Chien CT, Chang PY, Hsieh MY, Jui HY, Liau CS, Hsu SM, Lee YT. High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity. Atherosclerosis 2005; 183: 251–258
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, Rye KA, Barter PJ. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 2005; 111: 1543–1550
   PubMed Web of Science ®Google Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494–501
   PubMed Web of Science ®Google Scholar
• Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 23–28
   PubMed Web of Science ®Google Scholar
• Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res 1999; 40: 345–353
   PubMed Web of Science ®Google Scholar
• Peshavariya HM, Dusting GJ, Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res 2007; 41: 699–712
   PubMed Web of Science ®Google Scholar
• Jiang F, Guo Y, Salvemini D, Dusting GJ. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br J Pharmacol 2003; 139: 1127–1134
   PubMed Web of Science ®Google Scholar
• Furuchi T, Anderson RG. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 1998; 273: 21099–21104
   PubMed Web of Science ®Google Scholar
• Jiang F, Guo N, Dusting GJ. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3′,4′-dihydroxyflavonol in phagocytic and vascular cells. J Pharmacol Exp Ther 2008; 324: 261–269
   PubMed Web of Science ®Google Scholar
• Guichard C, Pedruzzi E, Dewas C, Fay M, Pouzet C, Bens M, Vandewalle A, Ogier-Denis E, Gougerot-Pocidalo MA, Elbim C. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 2005; 280: 37021–37032
   PubMed Web of Science ®Google Scholar
• Ilangumaran S, Briol A, Hoessli DC. Distinct interactions among GPI-anchored, transmembrane and membrane associated intracellular proteins, and sphingolipids in lymphocyte and endothelial cell plasma membranes. Biochim Biophys Acta 1997; 1328: 227–236
   PubMed Web of Science ®Google Scholar
• Barber DA, Do NH, Tackett RL, Capomacchia AC. Nonsuperoxide lucigenin-enhanced chemiluminescence from phospholipids and human saphenous veins. Free Radic Biol Med 1995; 18: 565–569
   PubMed Web of Science ®Google Scholar
• Tonks A, Parton J, Tonks AJ, Morris RH, Finall A, Jones KP, Jackson SK. Surfactant phospholipid DPPC downregulates monocyte respiratory burst via modulation of PKC. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1070–L1080
   Web of Science ®Google Scholar
• Vilhardt F, van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. Embo J 2004; 23: 739–748
   PubMed Web of Science ®Google Scholar
• Furlaneto C, Campa A. The effect in vitro of high-density lipoprotein from healthy and infected humans on the oxidative metabolism of polymorphonuclear leukocytes. Cell Biochem Funct 1997; 15: 39–45
   PubMed Web of Science ®Google Scholar
• Tso C, Martinic G, Fan WH, Rogers C, Rye KA, Barter PJ. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 2006; 26: 1144–1149
   PubMed Web of Science ®Google Scholar
• Chander R, Kapoor NK. High density lipoprotein is a scavenger of superoxide anions. Biochem Pharmacol 1990; 40: 1663–1665
   PubMed Web of Science ®Google Scholar
• Shao D, Segal AW, Dekker LV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 2003; 550: 101–106
   PubMed Web of Science ®Google Scholar
• Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler Thromb Vasc Biol 2007; 27: 1346–1353
   PubMed Web of Science ®Google Scholar
• Paterno R, Ruocco A, Postiglione A, Hubsch A, Andresen I, Lang MG. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 2004; 17: 204–211
   PubMed Web of Science ®Google Scholar
• Ago, T, Kitazono, T, Ooboshi, H, Iyama, T, Han, YH, Takada, J, Wakisaka, M, Ibayashi, S, Utsumi, H, Iida, M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004;109:227–233. Epub 2004 Jan 12.
   PubMed Web of Science ®Google Scholar
• Jiang F, Roberts SJ, raju Datla S, Dusting GJ. Nitric oxide modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006; 48: 950–957
   PubMed Web of Science ®Google Scholar
• Kawahara T, Ritsick D, Cheng G, Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 2005; 280: 31859–31869
   PubMed Web of Science ®Google Scholar
• Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 2007; 406: 105–114
   PubMed Web of Science ®Google Scholar
• Van Buul JD, Fernandez-Borja M, Anthony EC, Hordijk PL. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 2005; 7: 308–317
   PubMed Web of Science ®Google Scholar
• Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000; 87: 26–32
   PubMed Web of Science ®Google Scholar
• Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 1903–1911
   PubMed Web of Science ®Google Scholar
• Li JM, Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002; 277: 19952–19960
   PubMed Web of Science ®Google Scholar
• Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res 2000; 41: 1261–1267
   PubMed Web of Science ®Google Scholar
• Yoshida K, Mohsenin V. Unsaturated phosphatidylcholines inhibit superoxide production in human neutrophils. Life Sci 1991; 49: 1359–1365
   PubMed Web of Science ®Google Scholar